{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:58:45Z","timestamp":1778803125783,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570182"],"award-info":[{"award-number":["81570182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2013CB733701"],"award-info":[{"award-number":["2013CB733701"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013286","name":"Specialized Research Fund for the Doctoral Program of Higher Education of China","doi-asserted-by":"crossref","award":["20130001110079"],"award-info":[{"award-number":["20130001110079"]}],"id":[{"id":"10.13039\/501100013286","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Program of National Natural Science Foundation of China","award":["81530046"],"award-info":[{"award-number":["81530046"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10495-016-1276-8","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T15:47:52Z","timestamp":1469807272000},"page":"1179-1190","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Synergistic antitumor activity of triple-regulated oncolytic adenovirus with VSTM1 and daunorubicin in leukemic cells"],"prefix":"10.1007","volume":"21","author":[{"given":"Jiao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Mei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Lan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Ling","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Jun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Rui","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,29]]},"reference":[{"key":"1276_CR1","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.18632\/oncotarget.2901","volume":"6","author":"O Hemminki","year":"2015","unstructured":"Hemminki O, Parviainen S, Juhila J, Turkki R, Linder N, Lundin J et al (2015) Immunological data from cancer patients treated with Ad5\/3-E2F-\u039424-GMCSF suggests utility for tumor immunotherapy. Oncotarget 6:4467\u20134481","journal-title":"Oncotarget"},{"key":"1276_CR2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/CJI.0000000000000028","volume":"37","author":"L Liljenfeldt","year":"2014","unstructured":"Liljenfeldt L, Yu D, Chen L, Essand M, Mangsbo SM (2014) A hexon and fiber-modified adenovirus expressing CD40L improves the antigen presentation capacity of dendritic cells. J Immunother 37:155\u2013162","journal-title":"J Immunother"},{"key":"1276_CR3","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1158\/0008-5472.CAN-11-3368","volume":"72","author":"JE Castro","year":"2012","unstructured":"Castro JE, Melo-Cardenas J, Urquiza M, Barajas-Gamboa JS, Pakbaz RS, Kipps TJ (2012) Gene immunotherapy of chronic lymphocytic leukemia: a phase I study of intranodally injected adenovirus expressing a chimeric CD154 molecule. Cancer Res 72:2937\u20132948","journal-title":"Cancer Res"},{"key":"1276_CR4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/cgt.2013.79","volume":"21","author":"G Ma","year":"2014","unstructured":"Ma G, Kawamura K, Shan Y, Okamoto S, Li Q, Namba M et al (2014) Combination of adenoviruses expressing melanoma differentiation-associated gene-7 and chemotherapeutic agents produces enhanced cytotoxicity on esophageal carcinoma. Cancer Gene Ther 21:31\u201337","journal-title":"Cancer Gene Ther"},{"key":"1276_CR5","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3892\/mmr.2014.2785","volume":"11","author":"T Li","year":"2015","unstructured":"Li T, Guo X, Wang W, Mo X, Wang P, Han W (2015) V-set and transmembrane domain-containing 1 is silenced in human hematopoietic malignancy cell lines with promoter methylation and has inhibitory effects on cell growth. Mol Med Rep 11:1344\u20131351","journal-title":"Mol Med Rep"},{"key":"1276_CR6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/mab.2012.0119","volume":"32","author":"T Li","year":"2013","unstructured":"Li T, Wang W, Chen Y, Han W (2013) Preparation and characterization of monoclonal antibodies against VSTM1. Monoclon Antib Immunodiagn Immunother 32:283\u2013289","journal-title":"Monoclon Antib Immunodiagn Immunother"},{"key":"1276_CR7","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.4049\/jimmunol.0902039","volume":"184","author":"TA Steevels","year":"2010","unstructured":"Steevels TA, Lebbink RJ, Westerlaken GH, Coffer PJ, Meyaard L (2010) Signal inhibitory receptor on leukocytes-1 is a novel functional inhibitory immune receptor expressed on human phagocytes. J Immunol 184:4741\u20134748","journal-title":"J Immunol"},{"key":"1276_CR8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cellimm.2012.07.009","volume":"278","author":"X Guo","year":"2012","unstructured":"Guo X, Zhang Y, Wang P, Li T, Fu W, Mo X et al (2012) VSTM1-v2, a novel soluble glycoprotein, promotes the differentiation and activation of Th17 cells. Cell Immunol 278:136\u2013142","journal-title":"Cell Immunol"},{"key":"1276_CR9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13045-015-0118-4","volume":"8","author":"M Xie","year":"2015","unstructured":"Xie M, Li T, Li N, Li J, Yao Q, Han W et al (2015) VSTM-v1 is a potential myeloid differentiation antigen gene that is downregulated in bone marrow cells from patients with myeloid leukemia. J Hematol Oncol 8:25","journal-title":"J Hematol Oncol"},{"key":"1276_CR10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ijc.25948","volume":"129","author":"G Jiang","year":"2011","unstructured":"Jiang G, Xin Y, Zheng JN, Liu YQ (2011) Combining conditionally replicating adenovirus-mediated gene therapy with chemotherapy: a novel antitumor approach. Int J Cancer 129:263\u2013274","journal-title":"Int J Cancer"},{"key":"1276_CR11","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1158\/1078-0432.CCR-0349-03","volume":"10","author":"RL Chu","year":"2004","unstructured":"Chu RL, Post DE, Khuri FR, Van Meir EG (2004) Use of replicating oncolytic adenoviruses in combination therapy for cancer. Clin Cancer Res 10:5299\u20135312","journal-title":"Clin Cancer Res"},{"key":"1276_CR12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bcp.2014.05.003","volume":"90","author":"C Bressy","year":"2014","unstructured":"Bressy C, Benihoud K (2014) Association of oncolytic adenoviruses with chemotherapies: an overview and future directions. Biochem Pharmacol 90:97\u2013106","journal-title":"Biochem Pharmacol"},{"key":"1276_CR13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1667\/0033-7587(2001)155[0188:TATIFC]2.0.CO;2","volume":"155","author":"JW Shay","year":"2001","unstructured":"Shay JW, Wright WE (2001) Telomeres and telomerase: implications for cancer and aging. Radiat Res 155:188\u2013193","journal-title":"Radiat Res"},{"key":"1276_CR14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S1359-6446(04)03202-7","volume":"9","author":"KS Hewitson","year":"2004","unstructured":"Hewitson KS, Schofield CJ (2004) The HIF pathway as a therapeutic target. Drug Discov Today 9:704\u2013711","journal-title":"Drug Discov Today"},{"key":"1276_CR15","first-page":"591","volume":"130","author":"CQ Su","year":"2004","unstructured":"Su CQ, Sham J, Xue HB, Wang XH, Chua D, Cui ZF et al (2004) Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells. J Cancer Res Clin Oncol 130:591\u2013603","journal-title":"J Cancer Res Clin Oncol"},{"key":"1276_CR16","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1158\/1078-0432.CCR-06-1491","volume":"12","author":"Q Zhang","year":"2006","unstructured":"Zhang Q, Chen G, Peng L, Wang X, Yang Y, Liu C et al (2006) Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus. Clin Cancer Res 12:6523\u20136531","journal-title":"Clin Cancer Res"},{"key":"1276_CR17","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1158\/1535-7163.MCT-07-2429","volume":"7","author":"X Wang","year":"2008","unstructured":"Wang X, Su C, Cao H, Li K, Chen J, Jiang L et al (2008) A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers. Mol Cancer Ther 7:1598\u20131603","journal-title":"Mol Cancer Ther"},{"key":"1276_CR18","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/s10495-009-0373-3","volume":"14","author":"M Xie","year":"2009","unstructured":"Xie M, Niu JH, Chang Y, Qian QJ, Wu HP, Li LF et al (2009) A novel triple-regulated oncolytic adenovirus carrying PDCD5 gene exerts potent antitumor efficacy on common human leukemic cell lines. Apoptosis 14:1086\u20131094","journal-title":"Apoptosis"},{"key":"1276_CR19","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10495-008-0206-9","volume":"13","author":"GR Ruan","year":"2008","unstructured":"Ruan GR, Zhao HS, Chang Y, Li JL, Qin YZ, Liu YR et al (2008) Adenovirus-mediated PDCD5 gene transfer sensitizes K562 cells to apoptosis induced by idarubicin in vitro and in vivo. Apoptosis 13:641\u2013648","journal-title":"Apoptosis"},{"key":"1276_CR20","first-page":"936","volume":"15","author":"GR Ruan","year":"2007","unstructured":"Ruan GR, Chen SS, Chang Y, Li JL, Qin YZ, Li LD et al (2007) Adenovirus-mediated PDCD5 gene transfer sensitizes apoptosis of K562 cells induced by etoposide. Zhongguo Shi Yan Xue Ye Xue Za Zhi 15:936\u2013940","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"1276_CR21","first-page":"809","volume":"63","author":"H Davis","year":"1979","unstructured":"Davis H, Davis T (1979) Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations. Cancer Treat Rep 63:809\u2013815","journal-title":"Cancer Treat Rep"},{"key":"1276_CR22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJM198107163050305","volume":"305","author":"R Young","year":"1981","unstructured":"Young R, Ozols R, Myers C (1981) The anthracycline antineoplastic drugs. N Engl J Med 305:139\u2013153","journal-title":"N Engl J Med"},{"key":"1276_CR23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-125-1-199607010-00008","volume":"125","author":"K Shan","year":"1996","unstructured":"Shan K, Lincoff M, Young J (1996) Anthracycline-induced cardiotoxicity. Ann Intern Med 125:47\u201358","journal-title":"Ann Intern Med"},{"key":"1276_CR24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0166-0934(01)00316-0","volume":"96","author":"DD LaBarre","year":"2001","unstructured":"LaBarre DD, Lowy RJ (2001) Improvements in methods for calculating virus titer estimates from TCID50 and plaque assays. J Virol Methods 96:107\u2013126","journal-title":"J Virol Methods"},{"key":"1276_CR25","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.leukres.2005.12.028","volume":"30","author":"GR Ruan","year":"2006","unstructured":"Ruan GR, Qin YZ, Chen SS, Li JL, Ma X, Chang Y (2006) Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia. Leuk Res 30:1159\u20131165","journal-title":"Leuk Res"},{"key":"1276_CR26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jso.2930310402","volume":"31","author":"DM Euhus","year":"1986","unstructured":"Euhus DM, Hudd C, LaRegina MC, Johnson FE (1986) Tumor measurement in the nude mouse. J Surg Oncol 31:229\u2013234","journal-title":"J Surg Oncol"},{"key":"1276_CR27","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/eji.201242916","volume":"43","author":"TA Steevels","year":"2013","unstructured":"Steevels TA, van Avondt K, Westerlaken GH, Stalpers F, Walk J, Bont L et al (2013) Signal inhibitory receptor on leukocytes-1 (SIRL-1) negatively regulates the oxidative burst in human phagocytes. Eur J Immunol 43:1297\u20131308","journal-title":"Eur J Immunol"},{"key":"1276_CR28","doi-asserted-by":"crossref","first-page":"e78459","DOI":"10.1371\/journal.pone.0078459","volume":"8","author":"K Avondt Van","year":"2013","unstructured":"Van Avondt K, Fritsch-Stork R, Derksen RH, Meyaard L (2013) Ligation of signal inhibitory receptor on leukocytes-1 suppresses the release of neutrophil extracellular traps in systemic lupus erythematosus. PLoS One 8:e78459","journal-title":"PLoS One"},{"key":"1276_CR29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jbiosc.2015.05.016","volume":"121","author":"H Liu","year":"2016","unstructured":"Liu H, Zou X, Li T, Wang X, Yuan W, Chen Y et al (2016) Enhanced production of secretory glycoprotein VSTM1-v2 with mouse IgG\u03ba signal peptide in optimized HEK293F transient transfection. J Biosci Bioeng 121:133\u2013139","journal-title":"J Biosci Bioeng"},{"key":"1276_CR30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.yexcr.2015.01.017","volume":"332","author":"H Mu","year":"2015","unstructured":"Mu H, Wang N, Zhao L, Li S, Li Q, Chen L et al (2015) Methylation of PLCD1 and adenovirus-mediated PLCD1 overexpression elicits a gene therapy effect on human breast cancer. Exp Cell Res 332:179\u2013189","journal-title":"Exp Cell Res"},{"key":"1276_CR31","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/jcmm.12397","volume":"19","author":"Y Yang","year":"2015","unstructured":"Yang Y, Xu H, Huang W, Ding M, Xiao J, Yang D et al (2015) Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus. J Cell Mol Med 19:915\u2013923","journal-title":"J Cell Mol Med"},{"key":"1276_CR32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mt.2009.266","volume":"18","author":"M Yamamoto","year":"2010","unstructured":"Yamamoto M, Curiel DT (2010) Current issues and future directions of oncolytic adenoviruses. Mol Ther 18:243\u2013250","journal-title":"Mol Ther"},{"key":"1276_CR33","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2147\/OTT.S50483","volume":"7","author":"GX Chen","year":"2014","unstructured":"Chen GX, Zhang S, He XH, Liu SY, Ma C, Zou XP (2014) Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives. Onco Targets Ther 7:1901\u20131909","journal-title":"Onco Targets Ther"},{"key":"1276_CR34","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1517\/14712598.2013.845662","volume":"13","author":"H Tazawa","year":"2013","unstructured":"Tazawa H, Kagawa S, Fujiwara T (2013) Advances in adenovirus-mediated p53 cancer gene therapy. Expert Opin Biol Ther 13:1569\u20131583","journal-title":"Expert Opin Biol Ther"},{"key":"1276_CR35","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1158\/1535-7163.MCT-09-0367","volume":"8","author":"JJ Short","year":"2009","unstructured":"Short JJ, Curiel DT (2009) Oncolytic adenoviruses targeted to cancer stem cells. Mol Cancer Ther 8:2096\u20132102","journal-title":"Mol Cancer Ther"},{"key":"1276_CR36","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1111\/j.1745-7254.2007.00672.x","volume":"28","author":"QW Pan","year":"2007","unstructured":"Pan QW, Zhong SY, Liu BS, Liu J, Cai R, Wang YG et al (2007) Enhanced sensitivity of hepatocellular carcinoma cells to chemotherapy with a Smac-armed oncolytic adenovirus. Acta Pharmacol Sin 28:1996\u20132004","journal-title":"Acta Pharmacol Sin"},{"key":"1276_CR37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/aps.2009.16","volume":"30","author":"YM Wu","year":"2009","unstructured":"Wu YM, Zhang KJ, Yue XT, Wang YQ, Yang Y, Li GC et al (2009) Enhancement of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying MDA-7\/IL-24. Acta Pharmacol Sin 30:467\u2013477","journal-title":"Acta Pharmacol Sin"},{"key":"1276_CR38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00432-014-1835-8","volume":"141","author":"B Ma","year":"2015","unstructured":"Ma B, Wang Y, Zhou X, Huang P, Zhang R, Liu T et al (2015) Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin. J Cancer Res Clin Oncol 141:419\u2013429","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-016-1276-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-016-1276-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-016-1276-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T02:19:59Z","timestamp":1589681999000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-016-1276-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,29]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["1276"],"URL":"https:\/\/doi.org\/10.1007\/s10495-016-1276-8","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,29]]}}}